Duopharma Biotech Berhad (KLSE: DPHARMA)

Market Cap	1.17B
Revenue (ttm)	787.53M
Net Income (ttm)	56.06M
Shares Out	961.94M
EPS (ttm)	0.06
PE Ratio	20.95
Forward PE	15.19
Dividend	0.03 (2.28%)
Ex-Dividend Date	Aug 29, 2024

Volume	165,700
Open	1.220
Previous Close	1.230
Day's Range	1.220 - 1.230
52-Week Range	1.100 - 1.450
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About Duopharma Biotech Berhad

Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products comprising vitamins and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system, musculo-skeletal system, anti-infectives, and others. It also provides specialty p...

• Industry: Pharmaceutical Preparations
• Founded: 1978
• Employees: 1,650
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: DPHARMA

Financial Performance

In 2023, Duopharma Biotech Berhad's revenue was 704.73 million, an increase of 1.15% compared to the previous year's 696.72 million. Earnings were 52.65 million, a decrease of -24.91%.